Basal Cell Carcinoma Mimickers Webinar
Wednesday, August 23, 2017 • 7:30 pm CST • 90 minutes
ACMS Members and current ACMS & ACGME Fellows-in-Training.
Statement of Need
Basal cell carcinoma is the most common form of skin cancer. Histologic recognition is often straight-forward. However, other basaloid tumors – both benign and malignant – may mimic basal cell carcinoma. Lack of recognition may result in additional, unnecessary Mohs stages in the case of benign tumors and incomplete management in the case of malignant tumors. This webinar aims to refresh familiarity with common mimickers of basal cell carcinoma as seen on frozen section histology.
- Identify histopathology of benign and malignant mimickers of basal cell carcinoma as seen on frozen sections.
- Differentiate the various basaloid tumors encountered by the Mohs surgeon.
- Discuss challenging cases where accurate diagnosis of benign and malignant basaloid tumors leads to precise and efficient tumor extirpation while minimizing morbidity.
CME: 1.50 Credit Hours
- ACMS Members, Associate Applicants, Fellows-in-training: $75
- Non-members: $250
If you have already paid for and/or viewed the live webinar, click below to access the recording and claim your CME certificate.
Sailesh Konda, MD is Assistant Clinical Professor of Dermatology at the University of Florida Health System and Adjunct Assistant Professor of Dermatology at Loma Linda University Medical Center. He is Medical Director, Co-Director of Mohs Surgery and Surgical Dermatology, and Director of Cosmetic Dermatology and Laser Surgery. He completed his undergraduate and medical education at the George Washington University. He went on to complete an internship in internal medicine at Boston University/Boston Medical Center and worked as a research associate at the University of California, San Francisco. After completing his dermatology residency at Howard University Hospital, he received additional fellowship training in Mohs surgery at Loma Linda University Medical Center. Dr. Konda is a fellow of the American Academy of Dermatology, an associate member of the American College of Mohs Surgery, and a member of the American Society of Dermatologic Surgery.
Ravi S. Krishnan, MD, FACMS is a Mohs surgeon at the Virginia Mason Medical Center in Seattle where his practice is exclusively dedicated to Mohs and reconstructive surgery. He is also an Assistant Clinical Professor in the Division of Dermatology at the University of Washington School of Medicine. Dr. Krishnan received his medical degree and residency training at Baylor College of Medicine in Houston, TX. Upon completion of his dermatology residency, he received fellowship training in Mohs micrographic surgery at the Dayton Skin Surgery Center. After his fellowship, Dr. Krishnan was the Director of Dermatologic Surgery in the Department of Dermatology at the Indiana University School of Medicine. He is a fellow of the American College of Mohs Surgery, a fellow of the American Academy of Dermatology, and a member of the American Society for Dermatologic Surgery.
Mark A. Russell, MD, FACMS is Associate Professor of Dermatology, Otolaryngology, and Pathology at the University of Virginia Health System. He is Medical Director and Director of Mohs and Dermatologic Surgery in the Department of Dermatology. He received his medical degree from the Ohio State University School of Medicine. Dr. Russell completed his residency in Dermatology, and his fellowship in Mohs and Dermatologic Surgery, at Vanderbilt University Medical Center. He completed fellowship training in Dermatopathology at the University of Virginia. Dr. Russell is a fellow of the American Academy of Dermatology, the American College of Mohs Surgery, the American Society of Dermatologic Surgery, and the American Society of Dermatopathology. He is board certified in Dermatology and Dermatopathology. Dr. Russell specializes in the diagnosis, treatment, and prevention of skin cancer.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the American College of Mohs Surgery (ACMS). The ACMS is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The ACMS designates this internet enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
To comply with the ACCME Standards of Commercial Support on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing medical education activities under our auspices. The ACMS requires that all CME certified activities be developed free from the control of a commercial interest and be balanced, objective, and scientifically rigorous. Anyone with the ability to affect the content of an educational activity must disclose relevant financial relationships with commercial interests producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Disclosure of Discussion of Non-FDA Approved Uses for Pharmaceutical Products and/or Medical Devices
The ACMS requires that all faculty presenters identify and disclose any off-label uses for pharmaceutical and medical device products. The ACMS recommends that each physician fully review all the available data on new products or procedures prior to instituting them with patients.
As an organization accredited by the ACCME to sponsor continuing medical education activities, the ACMS is required to disclose any real or apparent conflicts of interest (COI) that any speakers may have related to the content of their presentations. The ACMS requires that all individuals (including spouse/domestic partner) in a position to control/influence content in a program designated for AMA Physician’s Recognition Award Category 1 credits™ disclose any financial interest/arrangement or affiliation with an ACCME-defined commercial organization that may impact on his/her presentation (i.e. grants, research support, honoraria, member of speakers’ bureau, consultant, major stock shareholder, etc.). In addition, the faculty member must disclose when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during the educational activity.
No Interests to Disclose:
Jeremy S. Bordeaux, MD, MPH, FACMS*
Jerry D. Brewer, MD, FACMS*
Ravi S. Krishnan, MD, FACMS*
Mark A. Russell, MD, FACMS*
Interests to Disclose:
Sailesh Konda, MD* Consultant/Independent Contractor - Science 37, Inc.; Gerson Lehrman Group's Council of Advisors (GLG)
*Indicates CME & Education Committee Members
**Having a financial relationship with an ACCME-defined commercial organization, or discussing an unlabeled use of a commercial product, may not prevent a faculty member from participating in the planning process. However, the existence of a relevant financial relationship must be disclosed, so that any relevant conflict of interest may be resolved prior to that individual’s participation in the CME activity.
The views expressed and the techniques presented by the speaker of the ACMS-sponsored educational activity are not necessarily shared or endorsed by the organizations. Anyone with the ability to affect the content of an educational activity must disclose relevant financial relationships with commercial interests producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, as well as any unapproved or off-label uses of medical devices or pharmaceutical agents that they discuss, describe, or demonstrate during their presentations. Participants should use their independent judgment in applying the information discussed in this webinar in the treatment of patients.